Novartis convenes experts to discuss new technologies in healthcare at Novartis International BioCamp

13th International Biotechnology Leadership Camp focuses on potential of new technologies to fundamentally transform biomedical research and the pharmaceutical business. Interactive program brings 60 top university students from 18 countries and territories to Novartis headquarters in Switzerland -   Over the course of three days, students will attend lectures, visit labs and work on a business case exploring opportunities of using digital technologies in healthcare               Novartis today opened the 13th International Biotechnology Leadership Camp (BioCamp). Over the course of three days more than 60 selected students from international universities will discuss and explore with biotechnology and business experts how patients around the world can benefit from innovative technologies. The digital age has the potential to fundamentally transform biomedical research and the pharmaceutical business. At BioCamp, students and experts will explore these opportunities and discuss ways in which this can benefit patients around the world. "As a leader in healthcare innovation, Novartis aims to leverage the fundamental transformation that the digital age will bring for biomedical research. This will bring great change to the pharmaceutical industry and is in the best interests of patients and society," said Joseph Jimenez, CEO of Novartis.